TrialJournal of diabetes investigation2017

Preventive effect of ipragliflozin on nocturnal hypoglycemia in patients with type 2 diabetes treated with basal-bolus insulin therapy: An open-label, single-center, parallel, randomized control study.

Fumitaka Okajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.